| abstract |
The present invention is directed to methods for treating, delaying, slowing the progression of, and / or preventing disorders; the methods comprise administering to a subject in need of these a therapeutically effective amount of therapy that comprises, consists or consists essentially of (a) cannagliflozin and (b) one or more ACE inhibitors or one or more ARB or one or more agonists of PPAR-gamma; and to methods for treating, delaying, slowing the progression of, and / or preventing fatty liver disorders (eg, NASH or NAFLD); The methods comprise administering to a subject in need of these a therapeutically effective amount of Canagliflozin. |